Important aspects to consider about GLP-1 and GIP
27 Jan 2025Reports showing that glucagon-like peptide (GLP-1) lowers glucose levels, and glucose-dependent insulinotropic polypeptide (GIP) stimulates insulin secretion led to the development of the first GLP-1 receptor agonist exenatide, followed by the dual GIP and GLP-1 receptor agonist tirzepatide. Uncover the importance of accurate quantitative methods for the precise measurements of these molecules, and explore some of the significant analytical factors that should be considered when measuring circulating GLP-1 and GIP.
Related products
Request Quote for All Products
BIOMARKER ANALYSIS SERVICES
MercodiaMercodia offers a wide range of bioanalytical testing solutions, including large molecules, biomarkers, biosimilars, peptides, and oligonucleotides. Our services are tailored to support pharmaceutical and biotechnology companies at every stage of drug development. Understanding the specific context of use of a biomarker is essential for designing a cost- and time-effective bioanalytical strategy.